These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36207984)

  • 1. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
    He CB; Wang J; Mao YZ; Lao XM; Li SP
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
    Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
    He C; Sun S; Huang X; Zhang Y; Lin X; Li S
    Front Oncol; 2020; 10():622318. PubMed ID: 33604301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
    He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
    BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
    He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
    Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study.
    Tasu JP; Herpe G; Damion J; Richer JP; Debeane B; Vionnet M; Rouleau L; Carretier M; Ferru A; Ingrand P; Tougeron D
    Eur Radiol; 2024 Oct; 34(10):6885-6895. PubMed ID: 38494526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
    He C; Wang J; Zhang Y; Lin X; Li S
    Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population.
    Kwon JH; Chung MJ; Park JY; Lee HS; Hwang HK; Kang CM; Lee WJ; Park MS; Kim N; Bang S; Kim MD
    Acta Radiol; 2021 Feb; 62(2):164-171. PubMed ID: 32295390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
    Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
    Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer.
    He C; Sun S; Zhang Y; Li S
    J Inflamm Res; 2021; 14():4795-4807. PubMed ID: 34584438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
    Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
    Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
    Oikonomou D; Karamouzis MV; Moris D; Dimitrokallis N; Papamichael D; Kountourakis P; Astras G; Davakis S; Papalampros A; Schizas D; Petrou AS; Felekouras E
    Am J Clin Oncol; 2021 Jul; 44(7):325-330. PubMed ID: 33979098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer.
    He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
    Front Oncol; 2020; 10():6. PubMed ID: 32038984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
    Marsanic P; Mellano A; Sottile A; De Simone M
    Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.